Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial

 Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial},
  author={Nicolette Perry and C C Bollen and Elaine K. Perry and Clive G Ballard},
  journal={Pharmacology Biochemistry and Behavior},

Figures and Tables from this paper

improves cognitive performance and mood in healthy adults ) with cholinesterase inhibiting properties
Oral consumption of an in vitro investigation of the cholinesterase inhibitory properties and phytochemical constituents of a S. lavandulaefolia essential oil led to improved performance of secondary memory and attention tasks, and reduced mental fatigue and increased alertness which were more pronounced 4-h post-dose.
Extracts of salvia species : relation to potential cognitive therapy
In vitro investigation of sage species for anti-cholinesterase activity demonstrates that the cholinergic activity of the extracts results from a complex interaction between their constituents is mainly due to the activity of a main constituents with a chemical degree of synergy level in Alzheimer's disease.
An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers
The overall pattern of results is consistent with a dose-related benefit to processes involved in efficient stimulus processing and/or memory consolidation rather than retrieval or working memory efficiency.
The psychopharmacology of European herbs with cognition-enhancing properties.
Several non-toxic, European herbal species have pan-cultural traditions as treatments for cognitive deficits, including those associated with ageing, and may well provide effective and well-tolerated treatments for dementia.
Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging?
A multi‐faceted review of medicinal plants or phytochemicals, including traditional uses, relevant bioactivities, psychological and clinical evidence on efficacy and safety, focuses on those for which there is promising clinical trial evidence in people with dementia, together with at least one other of these lines of supporting evidence.
Systematic Review of Clinical Trials Assessing Pharmacological Properties of Salvia Species on Memory, Cognitive Impairment and Alzheimer's Disease
The authors' review shows that S. officinalis and S. lavandulaefolia exert beneficial effects by enhancing cognitive performance both in healthy subjects and patients with dementia or cognitive impairment and is safe for this indication.
Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects
The effects of plants belonging to the genus Salvia and their constituents on cognitive skills including memory, attention and learning are detailed and their potential effects in dementia, including Alzheimer’s disease are examined.
Danshen diversity defeating dementia.
Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults
The results extend previous observations of improved cognitive performance and mood following AChE inhibitory sage extracts and suggest that the ability of well-tolerated terpenoid-containing extracts to beneficially modulate cholinergic function and cognitive performance deserves further attention.


Of three plants with reputed memory enhancing properties, extracts of sage (Salvia officinalis) inhibited the brain enzyme in a concentration dependant manner, indicating that the active plant constituent(s) may be an as yet unidentified compound(s).
Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial
The objective of this study was to assess the efficacy and safety of Salvia officinalis extract using a fixed dose (60 drops/day), in patients with mild to moderate Alzheimer's disease, over a 4‐month period.
In‐vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease
Results demonstrate that S. lavandulaefolia, its essential oil and some chemical constituents have properties relevant to the treatment of Alzheimer's disease and provide further data supporting the value of carrying out clinical studies in patients with Alzheimer's Disease using this plant species.
Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders
Plants and their constituents with pharmacological activities that may be relevant to the treatment of cognitive disorders, including enhancement of cholinergic function in the central nervous system, anti‐cholinesterase (anti‐ChE), antiinflammatory, antioxidant and oestrogenic effects, are discussed.
In‐vitro Inhibition of Human Erythrocyte Acetylcholinesterase by Salvia lavandulaefolia Essential Oil and Constituent Terpenes
Sage (Salvia spp) essential oil and some of its constituent terpenes on human erythrocyte acetylcholinesterase were examined in‐vitro to study the effects of Salvia lavandulaefolia Vahl on memory.
Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers
New anti-inflammatory treatment strategy in Alzheimer's disease.
It is proposed that the 5- LOX inflammatory cascade may take part in the process of aging-associated neurodegenerative diseases, and the role of 5-LOX in Neurodegeneration is pointed to and its relevance for anti-inflammatory therapy of AD is discussed.
Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development
  • N. Cutler, J. Sramek
  • Biology
    Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 2001
Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo.
It appears that S. lavandulaefolia oil, shown to inhibit choline esterase in vitro, also has an in vivo effect and this may help explain its traditional use for ailing memory.